Literature DB >> 28585125

Role of microtubule-associated protein tau phosphorylation in Alzheimer's disease.

Rong-Hong Ma1, Yao Zhang2, Xiao-Yue Hong3, Jun-Fei Zhang3, Jian-Zhi Wang4, Gong-Ping Liu5.   

Abstract

As a major microtubule-associated protein, tau plays an important role in promoting microtubule assembly and stabilizing microtubules. In Alzheimer's disease (AD) and other tauopathies, the abnormally hyperphosphorylated tau proteins are aggregated into paired helical filaments and accumulated in the neurons with the form of neurofibrillary tangles. An imbalanced regulation in protein kinases and protein phosphatases is the direct cause of tau hyperphosphorylation. Among various kinases and phosphatases, glycogen synthase kinase-3β (GSK-3β) and protein phosphatase 2A (PP2A) are the most implicated. Accumulation of the hyperphosphorylated tau induces synaptic toxicity and cognitive impairments. Here, we review the upstream factors or pathways that can regulate GSK-3β or PP2A activity mainly based on our recent findings. We will also discuss the mechanisms that may underlie tau-induced synaptic toxicity.

Entities:  

Keywords:  Alzheimer’s disease; glycogen synthase kinase-3β; protein phosphatase 2A; synaptic toxicity; tau

Mesh:

Substances:

Year:  2017        PMID: 28585125     DOI: 10.1007/s11596-017-1732-x

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  65 in total

1.  Losartan-induced hypotension leads to tau hyperphosphorylation and memory deficit.

Authors:  Xinghua Liu; Zhihong Wang; Yiyuan Xia; Guang Yu; Kuan Zeng; Hongbin Luo; Jichang Hu; Cheng-Xin Gong; Jian-Zhi Wang; Xin-Wen Zhou; Xiao-Chuan Wang
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

2.  Changes in dendritic complexity and spine morphology in transgenic mice expressing human wild-type tau.

Authors:  Dara L Dickstein; Hannah Brautigam; Steven D Stockton; James Schmeidler; Patrick R Hof
Journal:  Brain Struct Funct       Date:  2010-03-07       Impact factor: 3.270

3.  B vitamin deficiency promotes tau phosphorylation through regulation of GSK3beta and PP2A.

Authors:  Vincenzina Nicolia; Andrea Fuso; Rosaria A Cavallaro; Andrea Di Luzio; Sigfrido Scarpa
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

4.  Hypoxia-induced tau phosphorylation and memory deficit in rats.

Authors:  Chang-E Zhang; Xifei Yang; Lingyun Li; Xiaojing Sui; Qing Tian; Wei Wei; Jianzhi Wang; Gongping Liu
Journal:  Neurodegener Dis       Date:  2014-06-27       Impact factor: 2.977

5.  Ser9 phosphorylation causes cytoplasmic detention of I2PP2A/SET in Alzheimer disease.

Authors:  Guang Yu; Tonghai Yan; Ye Feng; Xinghua Liu; Yiyuan Xia; Hongbin Luo; Jian-Zhi Wang; Xiaochuan Wang
Journal:  Neurobiol Aging       Date:  2013-01-29       Impact factor: 4.673

6.  Overactivation of glycogen synthase kinase-3 by inhibition of phosphoinositol-3 kinase and protein kinase C leads to hyperphosphorylation of tau and impairment of spatial memory.

Authors:  Shi Jie Liu; Ai Hong Zhang; Hong Lian Li; Qun Wang; Heng Mei Deng; William J Netzer; Huaxi Xu; Jian Zhi Wang
Journal:  J Neurochem       Date:  2003-12       Impact factor: 5.372

7.  Role of glycogen synthase kinase 3 beta as a negative regulator of dorsoventral axis formation in Xenopus embryos.

Authors:  I Dominguez; K Itoh; S Y Sokol
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

8.  Knockdown of phosphotyrosyl phosphatase activator induces apoptosis via mitochondrial pathway and the attenuation by simultaneous tau hyperphosphorylation.

Authors:  Dan-Ju Luo; Qiong Feng; Zhi-Hao Wang; Dong-Sheng Sun; Qun Wang; Jian-Zhi Wang; Gong-Ping Liu
Journal:  J Neurochem       Date:  2014-06-16       Impact factor: 5.372

9.  Lithium attenuates scopolamine-induced memory deficits with inhibition of GSK-3β and preservation of postsynaptic components.

Authors:  Yuan-Yuan Wu; Xiong Wang; Lu Tan; Dan Liu; Xing-Hua Liu; Qun Wang; Jian-Zhi Wang; Ling-Qiang Zhu
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

10.  Glycogen synthase kinase-3β regulates leucine-309 demethylation of protein phosphatase-2A via PPMT1 and PME-1.

Authors:  Xiu-Qing Yao; Xia-Chun Li; Xiao-Xue Zhang; Yang-Yang Yin; Bin Liu; Dan-Ju Luo; Qun Wang; Jian-Zhi Wang; Gong-Ping Liu
Journal:  FEBS Lett       Date:  2012-06-22       Impact factor: 4.124

View more
  17 in total

1.  Cryptotanshinone Attenuates Amyloid-β42-induced Tau Phosphorylation by Regulating PI3K/Akt/GSK3β Pathway in HT22 Cells.

Authors:  Diyang Lyu; Jianping Jia
Journal:  Mol Neurobiol       Date:  2022-05-16       Impact factor: 5.590

2.  PINK1 overexpression prevents forskolin-induced tau hyperphosphorylation and oxidative stress in a rat model of Alzheimer's disease.

Authors:  Xiao-Juan Wang; Lin Qi; Ya-Fang Cheng; Xue-Fei Ji; Tian-Yan Chi; Peng Liu; Li-Bo Zou
Journal:  Acta Pharmacol Sin       Date:  2021-12-10       Impact factor: 7.169

3.  MiR-539-5p Decreases amyloid β-protein production, hyperphosphorylation of Tau and Memory Impairment by Regulating PI3K/Akt/GSK-3β Pathways in APP/PS1 Double Transgenic Mice.

Authors:  Yushu Jiang; Yuan Zhang; Li Su
Journal:  Neurotox Res       Date:  2020-05-15       Impact factor: 3.911

4.  Red Ginseng Inhibits Tau Aggregation and Promotes Tau Dissociation In Vitro.

Authors:  Soo Jung Shin; Yong Ho Park; Seong Gak Jeon; Sujin Kim; Yunkwon Nam; Sang-Muk Oh; Yong Yook Lee; Minho Moon
Journal:  Oxid Med Cell Longev       Date:  2020-06-30       Impact factor: 6.543

Review 5.  Epigenetic Modulation on Tau Phosphorylation in Alzheimer's Disease.

Authors:  Chao-Chao Yu; Tao Jiang; Ao-Fei Yang; Yan-Jun Du; Miao Wu; Li-Hong Kong
Journal:  Neural Plast       Date:  2019-04-10       Impact factor: 3.599

6.  Supplement of microbiota-accessible carbohydrates prevents neuroinflammation and cognitive decline by improving the gut microbiota-brain axis in diet-induced obese mice.

Authors:  Hongli Shi; Qiao Wang; Mingxuan Zheng; Shanshan Hao; Jeremy S Lum; Xi Chen; Xu-Feng Huang; Yinghua Yu; Kuiyang Zheng
Journal:  J Neuroinflammation       Date:  2020-03-04       Impact factor: 8.322

7.  Multiplexed Phosphoproteomic Study of Brain in Patients with Alzheimer's Disease and Age-Matched Cognitively Healthy Controls.

Authors:  Gajanan Sathe; Kiran Kumar Mangalaparthi; Ankit Jain; Jacqueline Darrow; Juan Troncoso; Marilyn Albert; Abhay Moghekar; Akhilesh Pandey
Journal:  OMICS       Date:  2020-03-17

8.  Direct Activation of Protein Phosphatase 2A (PP2A) by Tricyclic Sulfonamides Ameliorates Alzheimer's Disease Pathogenesis in Cell and Animal Models.

Authors:  Hui Wei; Hui-Liang Zhang; Xiao-Chuan Wang; Jia-Zhao Xie; Dan-Dan An; Lu Wan; Jian-Zhi Wang; Yi Zeng; Xi-Ji Shu; Jukka Westermarck; You-Ming Lu; Michael Ohlmeyer; Rong Liu
Journal:  Neurotherapeutics       Date:  2020-07       Impact factor: 6.088

Review 9.  Abnormal Homocysteine Metabolism: An Insight of Alzheimer's Disease from DNA Methylation.

Authors:  Tingting Pi; Bo Liu; Jingshan Shi
Journal:  Behav Neurol       Date:  2020-09-08       Impact factor: 3.342

10.  Cornel iridoid glycoside ameliorates cognitive deficits in APP/PS1/tau triple transgenic mice by attenuating amyloid-beta, tau hyperphosphorylation and neurotrophic dysfunction.

Authors:  Cuicui Yang; Xunjie Bao; Li Zhang; Yali Li; Lin Li; Lan Zhang
Journal:  Ann Transl Med       Date:  2020-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.